-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Corbus Pharmaceuticals Holdings, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2018 to Q4 2024.
- Corbus Pharmaceuticals Holdings, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2024 was 10.9M shares, a 152% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 10.9M shares, a 152% increase from 2023.
- Corbus Pharmaceuticals Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 4.33M shares, a 3.76% increase from 2022.
- Corbus Pharmaceuticals Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 4.17M shares, a 1.85% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)